Meanwhile, Increased expression of USP10 in prostate cancer cells in interaction with G3BP2 inhibits the P53 signaling pathway and causes a specific carcinogenic effect along the USP10 / G3BP2 / P53 pathway (Takayama et al., 2018). Here, TP53 is linked to prostate cancer.